RxParadigm

RxParadigm is a private U.S. healthcare technology company focused on pharmacy and drug-pricing infrastructure rather than therapeutic drug development. The company offers Tungsten+PLUS, a platform used by pharmaceutical manufacturers, covered entities, pharmacies, and other stakeholders to manage 340B program operations, rebate administration, duplicate discount identification, Medicaid rebate support, and Medicare Maximum Fair Price workflow. Its products are positioned as a centralized clearinghouse intended to simplify compliance, claims validation, reporting, payment reconciliation, and dispute resolution across the pharmaceutical supply chain. RxParadigm appears to be commercially active and is led by pharmacy benefit management industry veteran Mesfin Tegenu. The company is health-related, but it is not a biotech or pharma pipeline company with disclosed therapeutic assets.